SCHEMBL2886434

SCHEMBL2886434

FC(F)C(F)(F)C(F)(F)C(F)Cl

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10377787 0.89 ALDH1A1 (0.38) ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL333613 0.80 KDM4E (0.35)
SCHEMBL10376266 0.79 KDM4E (0.33) ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL28672514 0.78 KDM4E (0.34)
SCHEMBL22713825 0.78 KDM4E (0.34)
SCHEMBL10377773 0.74 ALDH1A1 (0.33) ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL10376225 0.74 ALDH1A1 (0.33) ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL250358 0.74 ALDH1A1 (0.33) ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL1991322 0.71 ALDH1A1 (0.32) ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL1993063 0.71 ALDH1A1 (0.32) ALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10359700-B2 Salt, acid generator, photoresist composition and process of producing photoresist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-07-23 US disclosed
US-20150338735-A1 SALT, ACID GENERATOR, PHOTORESIST COMPOSITION AND PROCESS OF PRODUCING PHOTORESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 US disclosed
US-9176379-B2 Resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-03 US disclosed
EP-1812149-B1 SEMIPERMEABLE COMPOSITE MEMBRANE, PRODUCTION PROCESS THEREOF AND TREATMENT METHOD FOR BORON-CONTAINING WATER TORAY INDUSTRIES (JP) 2013-06-12 EP disclosed
US-20120264059-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-18 US disclosed
US-7641054-B2 Composite semipermeable membrane, production process thereof, and element, fluid separation equipment and treatment method for boron-containing water using the same TORAY INDUSTRIES, INC. (JP) 2010-01-05 US disclosed
US-20080000843-A1 Composite Semipermeable Membrane, Production Process Thereof, and Element, Fluid Separation Equipment and Treatment Method for Boron-Containing Water Using the Same TORAY INDUSTRIES, INC. (JP) 2008-01-03 US disclosed
EP-1812149-A1 COMPOSITE SEMIPERMEABLE MEMBRANE, PRODUCTION PROCESS THEREOF, AND ELEMENT, FLUID SEPARATION EQUIPMENT AND TREATMENT METHOD FOR BORON-CONTAINING WATER USING THE SAME TORAY INDUSTRIES, INC. (JP) 2007-08-01 EP disclosed
WO-2006051888-A1 COMPOSITE SEMIPERMEABLE MEMBRANE, PRODUCTION PROCESS THEREOF, AND ELEMENT, FLUID SEPARATION EQUIPMENT AND TREATMENT METHOD FOR BORON-CONTAINING WATER USING THE SAME TORAY INDUSTRIES, INC. (JP) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150338735-A1 SALT, ACID GENERATOR, PHOTORESIST COMPOSITION AND PROCESS OF PRODUCING PHOTORESIST PATTERN CBR1, CBR3, C1R ALDH1A1 2184/4885HSD17B10 927/4885MEN1 2555/4885
US-10359700-B2 Salt, acid generator, photoresist composition and process of producing photoresist pattern CBR1, CBR3, C1R ALDH1A1 2184/4885HSD17B10 927/4885MEN1 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.